ClinConnect ClinConnect Logo
Search / Trial NCT06757023

A Clinical Follow-up Study on the Efficacy of Thumbtack Needle for Postoperative Sleep and Recovery Treatment

Launched by THE FIRST AFFILIATED HOSPITAL OF XIAMEN UNIVERSITY · Dec 25, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying the effects of a special treatment called thumbtack needle therapy on patients recovering from surgery. Specifically, it aims to see how this therapy can help improve sleep quality and overall recovery for individuals who have undergone breast cancer surgery while under general anesthesia. The researchers want to find out if this treatment can reduce sleep problems and help patients feel better faster after their operation.

To participate in this study, you should be a woman aged 18 to 55 who is having breast cancer surgery and is in good health according to specific standards. It’s important that you don’t have a history of chronic insomnia or have taken sleep medications recently. If you join the trial, you can expect to receive the thumbtack needle treatment and help contribute to important research that could improve recovery for future patients. Keep in mind that certain health conditions may prevent you from participating, so discussing your eligibility with your doctor is essential.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Patients undergoing breast cancer surgery with general anesthesia in the hospital;
  • 2. American Society of Anesthesiologists (ASA) classification I-II;
  • 3. Women aged 18-55 years;
  • 4. No history of chronic insomnia;
  • 5. Individuals who have not taken sedative-hypnotic drugs within the past month.
  • Exclusion Criteria:
  • 1. Those who do not meet the aforementioned inclusion criteria;
  • 2. A history of severe heart, brain, lung, or kidney diseases (such as acute coronary syndrome (ACS), severe heart failure classified as NYHA Class III or IV, severe arrhythmias, severe valvular disease; acute aortic disease, and severe peripheral vascular disease, etc.), or poor physical condition (including reduced exercise tolerance, multi-organ dysfunction, malnutrition, etc.);
  • 3. A history of sleep disorders and psychiatric history;
  • 4. Inability to receive thumb-tack needle treatment.

About The First Affiliated Hospital Of Xiamen University

The First Affiliated Hospital of Xiamen University is a leading medical institution dedicated to advancing healthcare through innovative clinical research and trials. As a prominent teaching hospital, it combines state-of-the-art facilities with a commitment to high-quality patient care and medical education. The hospital is at the forefront of various clinical studies, focusing on a wide array of specialties, and aims to enhance treatment methodologies and improve patient outcomes. With a team of experienced researchers and clinicians, the First Affiliated Hospital of Xiamen University plays a critical role in contributing to medical knowledge and addressing pressing health challenges.

Locations

Xiamen, Fujian, China

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported